American Capital Inks $291M Sale Of Pharma Co. SPL
American Capital Ltd. is selling pharmaceutical ingredient manufacturer and supplier SPL Acquisition Corp. to China's Shenzhen Hepalink Pharmaceutical Co. Ltd. for about $291 million in debt and equity proceeds, including escrows...To view the full article, register now.
Already a subscriber? Click here to view full article